Prestige Consumer Healthcare (PBH) Price to Sales (2010 - 2025)

Prestige Consumer Healthcare has reported Price to Sales for 16 years, with the latest figure at 10.3 in Q4 2025.

• On a quarterly basis, Price to Sales fell 22.71% year-over-year to 10.3 in Q4 2025; TTM through Dec 2025 was 2.65, a 23.54% decrease from a year earlier, with the FY2025 full-year figure at 3.73, up 16.01% from the prior year.
• Price to Sales was 10.3 for Q4 2025 at Prestige Consumer Healthcare, down from 10.95 in the prior quarter.
• The five-year high for Price to Sales was 15.75 in Q2 2025, with the low at 8.53 in Q3 2022.
• Average Price to Sales over 5 years is 11.29, with a median of 10.82 recorded in 2023.
• The sharpest annual moves came in 2021 and 2025: Price to Sales jumped 52.34% in 2021, then dropped 22.71% in 2025.
• Over 5 years, Price to Sales stood at 11.09 in 2021, then gained by 1.77% to 11.29 in 2022, then declined by 4.77% to 10.75 in 2023, then advanced by 23.95% to 13.32 in 2024, then decreased by 22.71% to 10.3 in 2025.
• The last three Price to Sales figures came in at 10.3 (Q4 2025), 10.95 (Q3 2025), and 15.75 (Q2 2025), per Business Quant data.